JF
GILD icon

JMN Financial’s Gilead Sciences GILD Stock Holding History

JMN Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Sell
3,977
-207
-5% -$27.3K 0.39% 67
2026
Q1 		$583K Buy
4,184
+508
+14% +$71.1K 0.57% 40
2025
Q4 		$451K Buy
+3,676
New +$447K 0.45% 58

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JMN Financial's GILD Position: Q2 2026 in Review

JMN Financial reduced its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, selling an estimated $27.3K and leaving 3,977 shares worth $503K. The position accounts for 0.39% of the portfolio, ranked #67.

JMN Financial first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $583K in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • JMN Financial held 3,977 shares of Gilead Sciences worth $503K as of Q2 2026.
  • JMN Financial sold 207 Gilead Sciences shares in Q2 2026, an estimated $27.3K.
  • Gilead Sciences made up 0.39% of JMN Financial's portfolio in Q2 2026, its #67 holding.
  • JMN Financial first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • JMN Financial's Gilead Sciences position peaked at $583K in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.